Serum Amyloid A Protein in Familial Mediterranean Fever

1985 ◽  
Vol 102 (1) ◽  
pp. 71 ◽  
Author(s):  
AARON KNECHT
2019 ◽  
Vol 45 (1) ◽  
Author(s):  
Maria Cristina Maggio ◽  
Maria Castiglia ◽  
Giovanni Corsello

Abstract Background Familial Mediterranean Fever is an autoinflammatory disease typically expressed with recurrent attacks of fever, serositis, aphthous stomatitis, rash. Only a few reports describe the association with hepatic involvement. Case presentation We describe the clinical case of a child affected, since the age of 1 year, by recurrent fever, aphthous stomatitis, rash, arthralgia, associated with abdominal pain, vomiting, lymphadenopathy. The diagnosis of Familial Mediterranean Fever was confirmed by the genetic study of MEFV gene; the homozygous mutation M694 V in exon was documented. A partial control of attacks was obtained with colchicine. The child continued to manifest only recurrent episodes of abdominal pain without fever, however serum amyloid A persisted high, in association with enhanced levels of CRP, AST and ALT (1.5 x n.v.). The dosage of colchicine was increased step by step and the patient achieved a better control of symptoms and biochemical parameters. However, the patient frequently needed an increase in the dose of colchicine, suggesting the possible usefulness of anti-interleukin-1 beta treatment. Conclusions The unusual presentation of Familial Mediterranean Fever with liver disease suggests the role of inflammasome in hepatic inflammation. Colchicine controls systemic inflammation in most of the patients; however, subclinical inflammation can persist in some of them and can manifest with increased levels of CRP, ESR, serum amyloid A also in attack-free intervals.


Pathobiology ◽  
2016 ◽  
Vol 83 (6) ◽  
pp. 295-300 ◽  
Author(s):  
Manal Wilson ◽  
Amany A. Abou-Elalla ◽  
Mervat Talaat Zakaria ◽  
Huda Marzouk ◽  
Hala Lotfy Fayed ◽  
...  

2019 ◽  
Vol 27 (1) ◽  
pp. 1-4
Author(s):  
Mustafa Çakan ◽  
Şerife Gül Karadağ ◽  
Ayşe Tanatar ◽  
Hafize Emine Sönmez ◽  
Nuray Aktay Ayaz

1991 ◽  
Vol 87 (4) ◽  
pp. 506-508 ◽  
Author(s):  
George H. Sack ◽  
C.Conover Talbot ◽  
Bruce G. McCarthy ◽  
Emily L. Harris ◽  
Daniel Kastner ◽  
...  

2019 ◽  
Vol 39 (1) ◽  
pp. 249-253
Author(s):  
Mustafa Çakan ◽  
Nuray Aktay Ayaz ◽  
Gonca Keskindemirci ◽  
Şerife Gül Karadağ ◽  
Ayşe Tanatar ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Hala M. Lofty ◽  
Huda Marzouk ◽  
Yomna Farag ◽  
Mohammad Nabih ◽  
Iman A. S. Khalifa ◽  
...  

Background and Objectives. SAA is an acute-phase reactant detected during an FMF attack or other inflammatory conditions. High SAA levels may increase the risk of amyloidosis. The aim of the study is to measure the serum amyloid A (SAA) level in a group of Egyptian children with familial Mediterranean fever (FMF) and study its various correlates, if any.Methods. The study enrolled seventy-one children with FMF.Results. SAA level was high in 78.9% of the studied patients with a mean of81.62±31.6 mg/L, and CRP was positive in 31% of patients. There was no significant releation between SAA level and any demographic or clinical manifestation. High SAA was more frequent in V726A allele (16.9%) followed by M694V allele (12.3%). Elevated SAA levels were more frequent in patients on low colchicine doses. Forty-five percent (45%) of patients have low adherence to colchicine therapy.Interpretation and Conclusion. High SAA levels were detected two weeks after last FMF attack in a large percentage of Egyptian FMF children. This indicates that subclinical inflammation continues during attack-free periods, and SAA could be used as a marker of it.


Sign in / Sign up

Export Citation Format

Share Document